LPL Financial’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,563
| Closed | -$9K | – | 4566 |
|
|
2022
Q3 | $9K | Sell |
12,563
-442
| -3% | -$317 | ﹤0.01% | 4343 |
|
|
2022
Q2 | $15K | Buy |
13,005
+400
| +3% | +$461 | ﹤0.01% | 4334 |
|
|
2022
Q1 | $26K | Buy |
12,605
+255
| +2% | +$526 | ﹤0.01% | 4091 |
|
|
2021
Q4 | $36K | Sell |
12,350
-8,709
| -41% | -$25.4K | ﹤0.01% | 4245 |
|
|
2021
Q3 | $89K | Sell |
21,059
-1,519
| -7% | -$6.42K | ﹤0.01% | 4142 |
|
|
2021
Q2 | $119K | Sell |
22,578
-899
| -4% | -$4.74K | ﹤0.01% | 4009 |
|
|
2021
Q1 | $109K | Buy |
23,477
+10,371
| +79% | +$48.2K | ﹤0.01% | 3887 |
|
|
2020
Q4 | $43K | Buy |
13,106
+1,728
| +15% | +$5.67K | ﹤0.01% | 3721 |
|
|
2020
Q3 | $38K | Buy |
11,378
+515
| +5% | +$1.72K | ﹤0.01% | 3437 |
|
|
2020
Q2 | $37K | Buy |
10,863
+241
| +2% | +$821 | ﹤0.01% | 3345 |
|
|
2020
Q1 | $41K | Buy |
+10,622
| New | +$41K | ﹤0.01% | 3090 |
|
|
2019
Q4 | – | Sell |
-46,480
| Closed | -$351K | – | 3421 |
|
|
2019
Q3 | $351K | Buy |
46,480
+8,460
| +22% | +$63.9K | ﹤0.01% | 2542 |
|
|
2019
Q2 | $515K | Buy |
+38,020
| New | +$515K | ﹤0.01% | 2253 |
|